Clinical Trial Update: A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial assessed valganciclovir syrup in pediatric solid organ transplant recipients for cytomegalovirus infection, with results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cytomegalovirus Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-10-31